being and becoming in the world
Published in the current BMJ is this ‘Feature Essay’: Why doctors have a moral imperative to prescribe and support medical cannabis: The BMJ have published online several rapid responses to this … Continue reading ‘Entrenched resistance in the medical profession’
In a previous post I shared this paper: The declarations of interest were given as follows: I have written the following open letter to the lead author: Sent: 22 May … Continue reading “uncritical partisan narrative”
This perspective has just been published in the Journal of Psychopharmacology. My brief response to one of the authors can be read here, alongside further details of the competing interests of … Continue reading “Antidepressants, withdrawal and addiction: where are we now?”
The story of ‘alcosynth’ was given yesterday in a number of the National papers. The subtitle in the Guardian stated that “. . . the race is on to get … Continue reading “. . . the race is on to get it to market”
I worry about this particular “renaissance”. Dr Mark Bolstridge has co-authored with Professor David Nutt:
The authors of this recently published perspective on antidepressants ask: “What’s the beef?” Here is my response: This is an extremely poorly written perspective: the language is clumsy and the … Continue reading “What’s the beef?”
There is no excerpt because this is a protected post.
Professor David Baldwin took chairmanship of the Royal College of Psychiatrists Psychopharmacology Committee when Professor Allan Young had completed his tenure as chair. Based on available evidence, and this is … Continue reading The Psychopharmacology Committee [Chaired by Paid Opinion Leaders]